Advertisement
UK markets close in 10 minutes

  • FTSE 100

    7,890.95
    +13.90 (+0.18%)
     

  • FTSE 250

    19,389.36
    -61.31 (-0.32%)
     

  • AIM

    744.26
    -1.03 (-0.14%)
     

  • GBP/EUR

    1.1637
    -0.0047 (-0.40%)
     

  • GBP/USD

    1.2415
    -0.0023 (-0.19%)
     

  • Bitcoin GBP

    52,000.80
    +524.79 (+1.02%)
     

  • CMC Crypto 200

    1,374.32
    +61.69 (+4.94%)
     

  • S&P 500

    4,995.10
    -16.02 (-0.32%)
     

  • DOW

    37,937.63
    +162.25 (+0.43%)
     

  • CRUDE OIL

    83.37
    +0.64 (+0.77%)
     

  • GOLD FUTURES

    2,409.00
    +11.00 (+0.46%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,747.28
    -90.12 (-0.51%)
     

  • CAC 40

    8,018.57
    -4.69 (-0.06%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?

Sarah Collins
Updated
Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?

Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.

Continue reading